New pill could tame lung inflammation in sarcoidosis
Disease control
Recruiting now
This study tests an experimental oral drug called OATD-01 for people with active pulmonary sarcoidosis, a condition causing lung inflammation. About 96 adults will receive either the drug or a placebo for 12 weeks to see if it reduces disease activity measured by PET scans. The g…
Phase: PHASE2 • Sponsor: Molecure S.A. • Aim: Disease control
Last updated May 15, 2026 11:54 UTC